Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

[up] Up a level
Number of items: 5.

Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441, Thomas, Abin ORCID: https://orcid.org/0000-0002-8283-6762, Hills, Robert K. ORCID: https://orcid.org/0000-0003-0166-0062, King, Sophie, Thomas, Ian, Marquez-Almuina, Nuria, Burns, Sarah, Gilkes, Amanda F., Irwin, Sarah, Sellar, Rob S., Green, Simone, Overgaard, Ulrik Malthe, Mehta, Priyanka, Dennis, Mike, Freeman, Sylvie D. and Russell, Nigel H. 2026. Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial. Blood 10.1182/blood.2025032681

Sheppard, Rory, Gianatsi, Myrsini, Thomas, Ian, King, Sophie, Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Pallmann, Philip ORCID: https://orcid.org/0000-0001-8274-9696, Marsal Barril, Sara and Choy, Ernest ORCID: https://orcid.org/0000-0003-4459-8609 2026. Decision on optimal combinatorial therapies in immune-mediated inflammatory diseases using systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis. Rheumatology Advances in Practice 10 (2) , rkag036. 10.1093/rap/rkag036
file

Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441, Dillon, Laura W., Babu, Malavika, Thomas, Abin ORCID: https://orcid.org/0000-0002-8283-6762, Thomas, Ian, Hourigan, Christopher S, Andrew, Georgia, Dillon, Richard, Gilkes, Amanda, Marquez Almuina, Nuria, King, Sophie, McCarthy, Nicholas, Bahr, Reem, Al-Ali, Rasha W, Stone, Louisa, Coats, Tom, Byrne, Jennifer, Green, Simone, Overgaard, Ulrik Malthe, Sellar, Rob S., Dennis, Mike, Mehta, Priyanka, Hills, Robert, Freeman, Sylvie D. and Russell, Nigel H 2026. CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18 trial. Blood 147 (10) , pp. 1048-1057. 10.1182/blood.2025031006
file

Knapper, Steven, Thomas, Abin ORCID: https://orcid.org/0000-0002-8283-6762, King, Sophie, Thomas, Ian, Gilkes, Amanda, Irwin, Sarah, Sellar, Robert, Green, Simone, Overgaard, Ulrik Malthe, Mehta, Priyanka, Dennis, Mike, Freeman, Sylvie and Russell, Nigel 2023. S131: a randomised assessment of the sequential addition of the kinase inhibitor Quizartinib to intensive chemotherapy in older acute myeloid leukaemia (AML) patients: results from the NCRI AML18 trial [Abstract]. HemaSphere 7 , pp. 69-70. 10.1097/01.hs9.0000967436.08196.70
file

Freeman, Sylvie D, Thomas, Abin, Thomas, Ian, Vyas, Paresh, Gilkes, Amanda, Metzner, Marlen, Jakobsen, Niels Asger, Kennedy, Alison, Moore, Amy, Marquez Almuina, Nuria, Burns, Sarah, King, Sophie, Andrew, Georgia M., Gallagher, Kathleen M.E., Sellar, Rob, Cahalin, Paul, Weber, Duruta, Dennis, Mike, Mehta, Priyanka, Knapper, Steve ORCID: https://orcid.org/0000-0002-6405-4441 and Russell, Nigel H. 2022. A randomized comparison of the fractionated versus single dose schedule of Gemtuzumab Ozogamicin at induction with determinants of benefit for older AML patients: UK NCRI AML18 trial results. Blood 140 (S1) , pp. 532-533. 10.1182/blood-2022-162245

This list was generated on Sun Sep 20 05:35:16 2026 BST.


Maintained by Cardiff University IT